Compare · CNC vs DGX
CNC vs DGX
Side-by-side comparison of Centene Corporation (CNC) and Quest Diagnostics Incorporated (DGX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNC and DGX operate in Medical Specialities (Health Care), so they compete in similar markets.
- CNC is the larger of the two at $30.78B, about 1.4x DGX ($22.17B).
- DGX has been more active in the news (13 items in the past 4 weeks vs 6 for CNC).
- Both have 25 recent analyst ratings on file.
- Company
- Centene Corporation
- Quest Diagnostics Incorporated
- Price
- $62.31-0.59%
- $200.30+2.06%
- Market cap
- $30.78B
- $22.17B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 6
- 13
- Recent ratings
- 25
- 25
Centene Corporation
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Latest CNC
- SEC Form 4 filed by Group President, Medicare&Spec Carson Michael A
- Five Stars: Health Net Recognized by USA TODAY for Customer Service; Only California-Based Health Insurer Recognized with Highest Rating
- SEC Form 4 filed by Group President, Medicare&Spec Carson Michael A
- Centene upgraded by Deutsche Bank with a new price target
- New insider Finke Daniel P claimed ownership of 228,127 shares (SEC Form 3)
- New insider Carson Michael A claimed ownership of 123,707 shares (SEC Form 3)
- Centene Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Leadership Update
- Director Tanji Kenneth was granted 3,992 shares, increasing direct ownership by 50% to 11,909 units (SEC Form 4)
- Director Samuels Theodore R. Ii was granted 3,992 shares, increasing direct ownership by 19% to 24,748 units (SEC Form 4)
- Director Ford Monte E was granted 3,992 shares, increasing direct ownership by 37% to 14,827 units (SEC Form 4)
Latest DGX
- CEO and President Davis J. E. sold $1,941,400 worth of shares (10,000 units at $194.14) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 132,423 units (SEC Form 4)
- Director Carter Robert B was granted 1,142 shares, increasing direct ownership by 42% to 3,853 units (SEC Form 4)
- Director Gregg Vicky B was granted 1,142 shares, increasing direct ownership by 7% to 18,314 units (SEC Form 4)
- Director Main Timothy L was granted 1,142 shares, increasing direct ownership by 4% to 27,439 units (SEC Form 4)
- Director Diaz Luis was granted 1,142 shares, increasing direct ownership by 28% to 5,196 units (SEC Form 4)
- Director Wentworth Timothy C was granted 1,142 shares, increasing direct ownership by 529% to 1,358 units (SEC Form 4)
- Director Doi Tracey was granted 1,142 shares, increasing direct ownership by 17% to 7,748 units (SEC Form 4)
- Director Ring Timothy M was granted 1,142 shares, increasing direct ownership by 4% to 31,140 units (SEC Form 4)
- Director Lassiter Wright Iii was granted 1,142 shares, increasing direct ownership by 12% to 10,317 units (SEC Form 4)
- Director Morrison Denise M was granted 1,142 shares, increasing direct ownership by 11% to 11,929 units (SEC Form 4)